Inclusion Criteria:  Patient that is newly diagnosed with uveitis of unknown origin/idiopathic (as evidenced by a series of uveitis work-up tests) and tested positive for IGRA (>0.35 U/ml). Age >18 years old Lives in Jakarta/Bogor/Depok/Tangerang/Bekasi area or willing to participate in research until the end of monitoring program Willing to participate in the research and sign the informed consent after receiving explanation regarding the research  Exclusion Criteria:  Patients with positive aqueous tap examination results on one of the examination panels for the bacteria causing infectious uveitis according to the standard examination Anterior uveitis patient with a positive HLA-B27 test result The patient is proven to have active TB or lives in the same house with an active TB patient Patients are included in the TB reactivation risk index group according to the 2018 WHO LTBI (Latent Tuberculosis Incident) Guideline HIV positive patient Patients with uveitis sanata at the first visit Patients with visual acuity less than 1/300 or showing signs of preptisis based on ophthalmological examination and ultrasound of the eye The patient has a history of previous ATT consumption Patients with impaired liver function or other systemic conditions which according to the Internal Medicine Department are not eligible to receive ATT The patient has a history of taking antibiotics in the last 1-2 weeks The patient is not willing to sign the informed consent The patient was pregnant at the first visit or was planning to become pregnant during the study period